Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001
edited by Randolph W. Evans, MD, David S. Baskin, MD, and Frank M. Yatsu, MD, 776 pp, with 26 illus, $99.50, ISBN 0-19-511936-3, New York, NY, Oxford University Press, 2000.
Looking at the title, one might expect a book characterized predominantly by statistics and percentages, probably very dull to read. This is far from the truth. This book was exceedingly well written, and I thoroughly enjoyed reading it.
The first chapters deal with important matters relating to prognosis, such as ethical and medicolegal issues. There are some very interesting cases mentioned that enlighten us on legal aspects. Also mentioned is the way in which clinical trials are carried out, with the different methods clearly explained with good examples. The following chapters look at each disease category separately—cerebrovascular disorders, cranial nerves and brainstem, and so on. Each of these chapters provides a clear summary of the different types of each disorder, how to approach the diagnosis, the treatments available, and the known outcome of each treatment. The outcomes have been thoroughly researched. Recent information on new diseases is included, such as information on Nepah encephalitis.
Papathanasiou ES. Prognosis of Neurological Disorders, 2nd ed. Arch Neurol. 2001;58(6):1020. doi: